Most recently, it has been recognized that conolidine and the above mentioned derivatives act around the atypical chemokine receptor three (ACKR3. Expressed in comparable areas as classical opioid receptors, it binds to a big selection of endogenous opioids. Compared with most opioid receptors, this receptor functions as a scavenger and won't activ… Read More